Overall Status

Recruiting (79)

Not yet recruiting (45)

Completed (38)

Active, not recruiting (26)

Terminated (25)

Unknown status (9)

Withdrawn (4)

Suspended (2)

Phase

phase 1 (62)

phase 2 (60)

phase 3 (33)

phase 1/phase 2 (28)

n/a (9)

phase 4 (7)

phase 2/phase 3 (3)

early phase 1 (1)

Study Documents

Clinical Study Report (2)

Individual Participant Data Set (2)

Informed Consent Form (2)

Statistical Analysis Plan (2)

Study Protocol (2)

Study-level clinical trial data (1)

Funder Type

Other (113)

Industry (108)

NIH (7)

Study Type

Interventional (203)

Observational (24)

Observational [Patient Registry] (1)

ELN

Showing 226 - 228 of 228

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Alzheimer's Disease Trial in United States (Bapineuzumab 0.5 mg/kg, Placebo Control, Bapineuzumab 1.0 m/kg)

Completed

Alzheimer's Disease

Bapineuzumab 0.5 mg/kg
+2 more

Birmingham, Alabama
+185 more

Oct 30, 2013

Alzheimer's Disease Trial in Worldwide (Bapineuzumab 0.5 mg/kg, Placebo Control, Bapineuzumab 1.0 m/kg)

Completed

Alzheimer's Disease

Bapineuzumab 0.5 mg/kg
+2 more

Birmingham, Alabama
+250 more

Oct 30, 2013

CML Trial in Petah tikva (Treatment modification based on molecular response at 3 months)

Unknown status

Treatment modification based on molecular response at 3 months

Petah tikva, Israel

Rabin Medical Center

Jan 7, 2013